RWD150 Tirzepatide and Weight Reduction Among Individuals without Evidence of Type 2 Diabetes: Descriptive Results from Optum’s De-Identified Market Clarity Data
Jun 1, 2024, 00:00
10.1016/j.jval.2024.03.1804
https://www.valueinhealthjournal.com/article/S1098-3015(24)01919-3/fulltext
Title :
RWD150 Tirzepatide and Weight Reduction Among Individuals without Evidence of Type 2 Diabetes: Descriptive Results from Optum’s De-Identified Market Clarity Data
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(24)01919-3&doi=10.1016/j.jval.2024.03.1804
First page :
Section Title :
Open access? :
No
Section Order :
11457